Comment
doi: 10.1200/JCO.2014.56.7792.
Epub 2014 Aug 18.
Focal therapy will become a standard option for selected men with localized prostate cancer
Affiliations
- PMID: 25135989
- DOI: 10.1200/JCO.2014.56.7792
Item in Clipboard
Comment
Focal therapy will become a standard option for selected men with localized prostate cancer
J Clin Oncol.
.
Free article
No abstract available
Comment in
-
Reply to M. Valerio et al.J Clin Oncol. 2014 Nov 10;32(32):3681-2. doi: 10.1200/JCO.2014.57.7353. Epub 2014 Aug 18. J Clin Oncol. 2014. PMID: 25135993 No abstract available.
Comment on
-
Will focal therapy remain only an attractive illusion for the primary treatment of prostate cancer?J Clin Oncol. 2014 May 1;32(13):1299-301. doi: 10.1200/JCO.2013.54.8214. Epub 2014 Mar 31. J Clin Oncol. 2014. PMID: 24687824 No abstract available.
Similar articles
-
A randomized controlled trial on focal therapy for localized prostate carcinoma: hemiablation versus complete ablation with irreversible electroporation.J Endourol. 2013 Mar;27(3):262-4. doi: 10.1089/end.2013.1568. J Endourol. 2013. PMID: 23469828 No abstract available.
-
Will focal therapy remain only an attractive illusion for the primary treatment of prostate cancer?J Clin Oncol. 2014 May 1;32(13):1299-301. doi: 10.1200/JCO.2013.54.8214. Epub 2014 Mar 31. J Clin Oncol. 2014. PMID: 24687824 No abstract available.
-
Evolution of Focal Therapy in Prostate Cancer: Past, Present, and Future.Urol Clin North Am. 2022 Feb;49(1):129-152. doi: 10.1016/j.ucl.2021.07.011. Epub 2021 Oct 23. Urol Clin North Am. 2022. PMID: 34776047 Review.
-
Step-by-Step Technique for Irreversible Electroporation of Focal Prostate Cancer: An Instructional Video Guide.J Vasc Interv Radiol. 2016 Apr;27(4):568. doi: 10.1016/j.jvir.2016.01.003. J Vasc Interv Radiol. 2016. PMID: 27013005
-
Making a case "for" focal therapy of the prostate in intermediate risk prostate cancer: current perspective and ongoing trials.World J Urol. 2021 Mar;39(3):729-739. doi: 10.1007/s00345-020-03525-0. Epub 2021 Jan 2. World J Urol. 2021. PMID: 33388878 Review.
Cited by
-
Radiotherapy planning in a prostate cancer phantom model with intraprostatic dominant lesions using stereotactic body radiotherapy with volumetric modulated arcs and a simultaneous integrated boost.Front Oncol. 2023 Apr 28;13:1147593. doi: 10.3389/fonc.2023.1147593. eCollection 2023. Front Oncol. 2023. PMID: 37188175 Free PMC article.
-
Pilot Study to Assess Safety and Clinical Outcomes of Irreversible Electroporation for Partial Gland Ablation in Men with Prostate Cancer.J Urol. 2016 Sep;196(3):883-90. doi: 10.1016/j.juro.2016.02.2986. Epub 2016 Apr 23. J Urol. 2016. PMID: 27113966 Free PMC article.
-
Histological characteristics of the largest and secondary tumors in radical prostatectomy specimens and implications for focal therapy.Diagn Pathol. 2019 Jan 12;14(1):2. doi: 10.1186/s13000-019-0782-8. Diagn Pathol. 2019. PMID: 30636627 Free PMC article.
-
Magnetic resonance guided focused high frequency ultrasound ablation for focal therapy in prostate cancer - phase 1 trial.Eur Radiol. 2018 Oct;28(10):4281-4287. doi: 10.1007/s00330-018-5409-z. Epub 2018 Apr 25. Eur Radiol. 2018. PMID: 29696431
-
Prospective evaluation of fexapotide triflutate injection treatment of Grade Group 1 prostate cancer: 4-year results.World J Urol. 2020 Dec;38(12):3101-3111. doi: 10.1007/s00345-020-03127-w. Epub 2020 Feb 22. World J Urol. 2020. PMID: 32088746 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
